Authors:
Nieto, Y
Champlin, RE
Wingard, JR
Vredenburgh, JJ
Elias, AD
Richardson, PR
Glaspy, J
Jones, RB
Stiff, PJ
Bearman, SI
Cagnoni, PJ
McSweeney, PA
LeMaistre, CF
Pecora, AL
Shpall, EJ
Citation: Y. Nieto et al., Status of high-dose chemotherapy for breast cancer: A review, BIOL BLOOD, 6(5), 2000, pp. 476-495
Authors:
Nieto, Y
Cagnoni, PJ
Bearman, SI
Shpall, EJ
Matthes, S
Jones, RB
Citation: Y. Nieto et al., Cardiac toxicity following high-dose cyclophosphamide, cisplatin, and BCNU(STAMP-I) for breast cancer, BIOL BLOOD, 6(2A), 2000, pp. 198-203
Authors:
Nieto, Y
Cagnoni, PJ
Nawaz, S
Shpall, EJ
Yerushalmi, R
Cook, B
Russell, P
McDermit, J
Murphy, J
Bearman, SI
Jones, RB
Citation: Y. Nieto et al., Evaluation of the predictive value of Her-2/neu overexpression and p53 mutations in high-risk primary breast cancer patients treated with high-dose chemotherapy and autologous stem-cell transplantation, J CL ONCOL, 18(10), 2000, pp. 2070-2080
Authors:
Nieto, Y
Russ, P
Everson, G
Bearman, SI
Cagnoni, PJ
Jones, RB
Shpall, EJ
Citation: Y. Nieto et al., Acute pancreatitis during immunosuppression with tacrolimus following an allogeneic umbilical cord blood transplantation, BONE MAR TR, 26(1), 2000, pp. 109-111
Authors:
McNiece, I
Jones, R
Bearman, SI
Cagnoni, P
Nieto, Y
Franklin, W
Ryder, J
Steele, A
Stoitz, J
Russell, P
McDermitt, J
Hogan, C
Murphy, J
Shpall, EJ
Citation: I. Mcniece et al., Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer, BLOOD, 96(9), 2000, pp. 3001-3007
Authors:
McNiece, I
Jones, R
Cagnoni, P
Bearman, S
Nieto, Y
Shpall, EJ
Citation: I. Mcniece et al., Ex-vivo expansion of hematopoietic progenitor cells: preliminary results in breast cancer, HEM CELL TH, 41(2), 1999, pp. 82-86
Authors:
Nieto, Y
Cagnoni, PJ
Shpall, EJ
Matthes, S
Baron, A
Jones, RB
Bearman, SI
Citation: Y. Nieto et al., Phase II trial of high-dose chemotherapy with autologous stem cell transplant for stage IV breast cancer with minimal metastatic disease, CLIN CANC R, 5(7), 1999, pp. 1731-1737
Authors:
Nieto, Y
Xu, XH
Cagnoni, PJ
Matthes, S
Shpall, EJ
Bearman, SI
Murphy, J
Jones, RB
Citation: Y. Nieto et al., Nonpredictable pharmacokinetic behavior of high-dose cyclophosphamide in combination with cisplatin and 1,3-bis(2-chloroethyl)-1-nitrosourea, CLIN CANC R, 5(4), 1999, pp. 747-751
Authors:
Nieto, Y
Cagnoni, PJ
Shpall, EJ
Xu, XS
Murphy, J
Vredenburgh, J
Chao, NJ
Bearman, SI
Jones, RB
Citation: Y. Nieto et al., A predictive model for relapse in high-risk primary breast cancer patientstreated with high-dose chemotherapy and autologous stem-cell transplant, CLIN CANC R, 5(11), 1999, pp. 3425-3431
Authors:
Bearman, SI
Vredenburh, JJ
Cagnoni, PJ
Shpall, EJ
Nieto, Y
Ross, M
Peters, WP
Jones, RB
Citation: Si. Bearman et al., High-dose therapy with autologous hematopoietic cell support as salvage treatment for patients with breast cancer who have relapsed after previous high-dose chemotherapy, BONE MAR TR, 24(5), 1999, pp. 491-495
Authors:
Nieto, Y
Ross, M
Gianani, R
Shpall, EJ
Cagnoni, PJ
Bearman, SI
Jones, RB
Citation: Y. Nieto et al., Post-mortem incidental finding of cytomegalovirus oophoritis after an allogeneic stem cell transplant, BONE MAR TR, 23(12), 1999, pp. 1323-1324
Authors:
Nieto, Y
Alonso, JL
Ayala, F
Ortega, L
Casado, A
Martin, M
Diaz-Rubio, E
Citation: Y. Nieto et al., End-stage acute hepatic failure as clinical presentation of liver metastases from breast cancer, TUMORI, 84(5), 1998, pp. 616-617